Gut Microbiome Effects Emerging research suggests that GLP-1 receptor agonists may favorably alter the gut microbiome, reducing gut permeability (leaky gut) and the translocation of bacterial endotoxins that trigger systemic inflammation
Patients who use appetite suppression to improve diet quality (more protein, more vegetables, fewer processed foods) see better results than those who simply eat smaller portions of the same foods
Novo Nordisk partnered with Saudi Arabias Lifera to localize semaglutide production
doi: 10.1186/s12967-018-1748-4 104
Therefore, we conducted a systematic review and meta-analysis to evaluate the current evidence regarding the outcomes associated with GLP-1RAs treatment in patients following bariatric surgery
Since GLP-1 acts on multiple pathways that are not fully addressed by other therapies, GLP-1 receptor agonists (drugs that mimic GLP-1 to improve insulin response and reduce glucose levels) have become the foundation for medications used in modern diabetes management 3
